
Josh Gottheimer
DHouseRepresentative · New Jersey
Sold up to $15,000 of AbbVie (ABBV)
Trade dated May 5, 202629 days to disclose
ABBV since the sale
+9.1%
S&P 500, same window
+4.6%
▲ ABBV beat the S&P 500 by 4.5 points since the sale
Price move from the trade date's close to the most recent close. A sale is favorable when the stock fell after.
On the public record around this trade
Committee activity, sponsored or cosponsored bills, and floor votes in this sector within 90 days — alongside the trade and its disclosure. Dated public record; draw your own conclusions.
- Apr 16, 2026Floor voteResult: Passed
- Apr 21, 2026Floor voteResult: Passed
- Apr 27, 2026Floor voteResult: Passed
- Apr 28, 2026LegislationPharmaceutical sector
- Apr 29, 2026LegislationPharmaceutical sector
- May 4, 2026LegislationPharmaceutical sector
- May 5, 2026TradeSold up to $15,000 of ABBV
- May 13, 2026LegislationPharmaceutical sector
- May 15, 2026LegislationPharmaceutical sector
- May 20, 2026CommitteePartnering for Innovation: How Bank-Fintech Collaborations Enhance Financial Infrastructure
- May 20, 2026CommitteeFrom Order to Execution: Ensuring Efficient and Transparent Equity Markets
- May 21, 2026CommitteeModernizing the BSA for Financial Crime in the 21st Century
- Jun 3, 2026DisclosureDisclosed the tradePublic filing
Get an alert the moment Josh Gottheimer files the next one
Capitol Markets tracks every Member of Congress in plain English — the trade, the price move, the committee overlap, the source filing.